MetLife Investment Management’s ChargePoint CHPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,946
Closed -$120K 2861
2025
Q1
$120K Sell
9,946
-2,612
-21% -$43.5K ﹤0.01% 2442
2024
Q4
$269K Buy
12,558
+1,118
+10% +$27.7K ﹤0.01% 2145
2024
Q3
$313K Buy
11,440
+6,446
+129% +$224K ﹤0.01% 2044
2024
Q2
$151K Buy
4,994
+3,911
+361% +$127K ﹤0.01% 2411
2024
Q1
$41.2K Buy
1,083
+153
+16% +$6K ﹤0.01% 2735
2023
Q4
$43.5K Buy
930
+12
+1% +$671 ﹤0.01% 2782
2023
Q3
$91.2K Buy
918
+59
+7% +$8.56K ﹤0.01% 2621
2023
Q2
$151K Buy
859
+92
+12% +$16.1K ﹤0.01% 2437
2023
Q1
$161K Buy
767
+2
+0.3% +$436 ﹤0.01% 2351
2022
Q4
$146K Sell
765
-11
-1% -$2.67K ﹤0.01% 2428
2022
Q3
$229K Buy
776
+160
+26% +$48.6K ﹤0.01% 2205
2022
Q2
$169K Buy
616
+388
+170% +$108K ﹤0.01% 2430
2022
Q1
$90.6K Buy
+228
New +$70.3K ﹤0.01% 2635

Other funds holding CHPT

MetLife Investment Management's CHPT Position: Q2 2025 in Review

MetLife Investment Management sold out of ChargePoint (CHPT) in Q2 2025, closing a stake of 9,946 shares — an estimated $120K sold.

MetLife Investment Management first reported a position in CHPT in Q1 2022 and held it in 13 quarters. The position peaked at $313K in Q3 2024. 246 funds tracked by Wall St. Rank hold CHPT as of Q2 2025.

  • MetLife Investment Management reported no remaining ChargePoint position as of Q2 2025 after selling out during the quarter.
  • MetLife Investment Management sold 9,946 ChargePoint shares in Q2 2025, an estimated $120K.
  • MetLife Investment Management first reported a position in ChargePoint in Q1 2022 and held it in 13 quarters.
  • MetLife Investment Management's ChargePoint position peaked at $313K in Q3 2024.
  • 246 funds tracked by Wall St. Rank held ChargePoint as of Q2 2025.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.